IL17A and psoriasis: The efficacy of TNF-α inhibitors against psoriasis underscores the importance of this cytokine in the disease, although the percentage of patients that experience marked improvements in their conditions is significantly lower than is the case after treatment with IL-17 or IL-23 inhibitors [10].